COMMUNIQUÉS West-GlobeNewswire
      -   
  
TLX250-CDx (Zircaix) Included in Leading International Guidelines for Renal Imaging
23/10/2025 -   
  
Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 Study with Vopimetostat (TNG462) in Patients with MTAP-deleted Cancers
23/10/2025 -   
  
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025
23/10/2025 -   
  
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025
23/10/2025 -   
  
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
23/10/2025 -   
  
Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work
23/10/2025 -   
  
Conavi Medical to Highlight Novasight Hybrid™ Imaging at TCT 2025
23/10/2025 -   
  
Amphista Therapeutics announces three key strategic leadership appointments to drive transition of its Targeted Glue™ protein degraders into clinical development
23/10/2025 -   
  
TRIDENT, a dedicated stroke outcomes trial in patients with a history of intracerebral hemorrhage (ICH), demonstrates the potential advantages of intensive blood pressure treatment with low-dose triple combination therapyTRIDENT, a dedicate
23/10/2025 -   
  
EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025
23/10/2025 -   
  
BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
23/10/2025 -   
  
Nicox : Résultats financiers du premier semestre 2025
23/10/2025 -   
  
Nicox Provides First Half 2025 Financial Results
23/10/2025 -   
  
Changes to the Roche Enlarged Corporate Executive Committee
23/10/2025 -   
  
Pharming Group to report third quarter 2025 financial results and provide business update on November 6
23/10/2025 -   
  
RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
23/10/2025 -   
  
Vantage Hemp Co. Strengthens Global Footprint with Initiation of European Regulatory Filings
23/10/2025 -   
  
NRG Therapeutics Announces Senior Appointments as it Advances NRG5051 Towards First-in-Human Clinical Studies
23/10/2025 -   
  
BrightCraft Dental Announces Comprehensive Sedation and Digital Full-Arch Transformation Model in Burbank
23/10/2025 
Pages